Drug application
QUALAQUIN (QUININE SULFATE)
Drugs@FDA NDA 021799 · SUN PHARM INDUSTRIES
Key facts
| Drug name | QUALAQUIN |
|---|---|
| Active ingredients | QUININE SULFATE |
| Application type | NDA |
| Application number | 021799 |
| Company | SUN PHARM INDUSTRIES |
| Dosage forms | CAPSULE, ORAL |
| Strength | 324MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Aug 12, 2005 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: